Skip to content
Open access

Cross‐tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease

Aug 2026 · Alzheimer's & Dementia · Vol 22 · 1 citation · 81 references
Medicine

Abstract

Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD), but its contribution to disease pathogenesis remains incompletely understood.

Read PDF

Similar papers

Open access Sep 2026

Transcriptional risk score for chronic kidney disease: relation to Alzheimer's disease

The impact of CKD transcriptional risk on AD endophenotypes is assessed by assessing the impact of CKD transcriptional risk on AD endophenotypes in individuals with chronic kidney disease.

Jung-Min Pyun, Young Ho Park, Jiyun Hwang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.